• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail

  • Print
  • Share
  • E-mail
Pediatric Labeling Date:  03/19/2007
Trade Name:  Keppra Tablets/ Keppra Oral Solution
Generic Name or Proper Name (*):  levetiracetam
Indications Studied:  Adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in children 6 years of age and older with idiopathic generalized epilepsy
Label Changes Summary:  * Safety and effectiveness established in study that included patients down to 4 years of age * Pediatric dosing information added * Studies waived in children 1 month to 2 years of age and deferred in children 2-6 years of age * New indication
Product Labeling:  Labeling  Opens a new window
Sponsor:  UCB
Therapeutic Category:  Anticonvulsant